Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents – Synthesis, molecular structure, QSAR studies and metabolic stability - Publication - Bridge of Knowledge

Search

Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents – Synthesis, molecular structure, QSAR studies and metabolic stability

Abstract

A series of new 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives have been synthesized and evaluated in vitro by MTT assays for their antiproliferative activity against cell lines of colon cancer HCT-116, cervical cancer HeLa and breast cancer MCF-7. The obtained results indicated that these compounds display prominent cytotoxic effect. The best anticancer properties have been observed for derivatives 44 (IC50 = 6-18 uM) and 45 (IC50 = 8-14 μM). Very good results of antiproliferative assays have been also shown for compounds 26, 36, and 46 and noticeable anticancer profile has been found for set of derivatives 34e39. Based on results of MTT assays the structure-activity relationships have been drawn. More in-depth biological research revealed that compounds 26, 33, 37, 39, 41 and 43 display cytotoxic effect only against cancer cells and do not inhibit the growth of nonmalignant HaCaT cells. Furthermore, the novel series of derivatives have shown good metabolic stability, especially among the pharmacologically active compounds. To obtain a deeper insight into the molecular description of compounds activity the QSAR studies have been applied. Support vector machines (SVM) have been used to developed QSAR models for predicting the anti-proliferative activity of novel derivatives. The obtained SVM models have shown prognostic ability for HCT-116 and HeLa cell lines and as a result these models may be useful for further development of structurally similar derivatives with better biological properties.

Citations

  • 1 7

    CrossRef

  • 0

    Web of Science

  • 1 9

    Scopus

Authors (9)

  • Photo of  Aneta Pogorzelska

    Aneta Pogorzelska

    • Medical University of Gdańsk Organic Chemistry
  • Photo of  Jarosław Sławiński

    Jarosław Sławiński

    • Medical University of Gdańsk Organic Chemistry
  • Photo of  Beata Żołnowska

    Beata Żołnowska

    • Medical University of Gdańsk Organic Chemistry
  • Photo of dr Krzysztof Szafrański

    Krzysztof Szafrański dr

    • Medical University of Gdańsk Organic Chemistry
  • Photo of  Anna Kawiak

    Anna Kawiak

    • Międzyuczelniany Wydział Biotechnologii UG i GUMed Wydział Biotechnologii
  • Photo of  Szymon Ulenberg

    Szymon Ulenberg

    • Medical University of Gdańsk Pharmaceutical Chemistry
  • Photo of  Joanna Zielińska

    Joanna Zielińska

    • Medical University of Gdańsk Pharmaceutical Chemistry
  • Photo of  Tomasz Bączek

    Tomasz Bączek

    • Medical University of Gdańsk Pharmaceutical Chemistry

Cite as

Full text

download paper
downloaded 78 times
Publication version
Accepted or Published Version
License
Creative Commons: CC-BY-NC-ND open in new tab

Keywords

Details

Category:
Articles
Type:
artykuł w czasopiśmie wyróżnionym w JCR
Published in:
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY no. 138, pages 357 - 370,
ISSN: 0223-5234
Language:
English
Publication year:
2017
Bibliographic description:
Pogorzelska A., Sławiński J., Żołnowska B., Szafrański K., Kawiak A., Chojnacki J., Ulenberg S., Zielińska J., Bączek T.: Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents – Synthesis, molecular structure, QSAR studies and metabolic stability// EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. -Vol. 138, (2017), s.357-370
DOI:
Digital Object Identifier (open in new tab) 10.1016/j.ejmech.2017.06.059
Verified by:
Gdańsk University of Technology

seen 173 times

Recommended for you

Meta Tags